Keith McCullagh is a seasoned bioscience entrepreneur with a passion for bringing innovative medicines to the market. He obtained his BVSc from the University of Bristol, followed by a Ph.D. from the University of Cambridge, and a post-doctoral fellowship at the Cleveland Clinic Foundation. After joining the pharmaceutical industry in 1980 and spending several years as Director of Biology/Director of Research at GD Searle & Co, McCullagh founded and built British Biotech, which he led from 1986 to 1998.
In addition to British Biotech, McCullagh also founded and developed internet healthcare businesses from 1999-2015 and was CEO of an RNA medicines business from 2003-2008. He is currently involved with the life science industry as a chairman, board member, advisor, or investor. McCullagh's extensive experience in the bioscience industry makes him an invaluable asset to any organization he works with.
Some of his notable positions include serving as Chairman at Metrion Biosciences, former Non-executive Chairman at Ario Pharma Ltd, and former CEO at Santaris Pharma A/S. Additionally, he served as Chairman at Pharmacy2U Ltd, Executive Chairman at OnMedica Ltd, and Non-executive Chairman at Xention Ltd, Torpedo Factory Group, and Taconic Biosciences Inc.